Lantheus Medical Imaging, Inc.

CIK:0001500157|SEC Filings

Condensed Consolidated Statements of Comprehensive Income (Loss) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Statement of Comprehensive Income [Abstract]
Revenues	$ 74,823us-gaap_Revenues	$ 73,336us-gaap_Revenues
Cost of goods sold	39,054us-gaap_CostOfGoodsSold	43,275us-gaap_CostOfGoodsSold
Gross profit	35,769us-gaap_GrossProfit	30,061us-gaap_GrossProfit
Operating expenses
Sales and marketing expenses	9,072us-gaap_SellingAndMarketingExpense	9,498us-gaap_SellingAndMarketingExpense
General and administrative expenses	8,841us-gaap_GeneralAndAdministrativeExpense	8,852us-gaap_GeneralAndAdministrativeExpense
Research and development expenses	6,196us-gaap_ResearchAndDevelopmentExpense	3,222us-gaap_ResearchAndDevelopmentExpense
Total operating expenses	24,109us-gaap_OperatingExpenses	21,572us-gaap_OperatingExpenses
Operating income	11,660us-gaap_OperatingIncomeLoss	8,489us-gaap_OperatingIncomeLoss
Interest expense, net	(10,623)us-gaap_InterestExpense	(10,552)us-gaap_InterestExpense
Other expense, net	(383)us-gaap_OtherNonoperatingIncomeExpense	(414)us-gaap_OtherNonoperatingIncomeExpense
Income (loss) before income taxes	654	(2,477)
Benefit for income taxes	(3)us-gaap_IncomeTaxExpenseBenefit	(1,192)us-gaap_IncomeTaxExpenseBenefit
Net income (loss)	657	(1,285)
Foreign currency translation	(358)	(271)
Total comprehensive income (loss)	$ 299us-gaap_ComprehensiveIncomeNetOfTax	$ (1,556)us-gaap_ComprehensiveIncomeNetOfTax

Guarantor Financial Information - Schedule of Condensed Consolidating Cash Flow Information (Detail) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Condensed Cash Flow Statements, Captions [Line Items]
Cash provided by operating activities	$ 15,157	$ (15)
Cash flows from investing activities
Capital expenditures	(3,498)	(1,482)
Proceeds from sale of property, plant and equipment		20
Cash used in investing activities	(3,498)	(1,462)
Cash flows from financing activities
Payments on note payable	(18)	(18)
Payments to parent	(441)	(45)
Cash used in financing activities	(459)	(63)
Effect of foreign exchange rate on cash	(196)	(41)
Increase (decrease) in cash and cash equivalents	11,004	(1,581)
Cash and cash equivalents, beginning of period	17,817	16,669
Cash and cash equivalents, end of period	28,821	15,088
Reportable Entities [Member] \| Parent Company [Member]
Cash flows from investing activities
Payments from subsidiary	441	45
Cash used in investing activities	441	45
Cash flows from financing activities
Payments to parent	(441)	(45)
Cash used in financing activities	(441)	(45)
Reportable Entities [Member] \| LMI [Member]
Condensed Cash Flow Statements, Captions [Line Items]
Cash provided by operating activities	16,289	1,797
Cash flows from investing activities
Capital expenditures	(3,376)	(1,465)
Proceeds from sale of property, plant and equipment		20
Cash used in investing activities	(3,376)	(1,445)
Cash flows from financing activities
Payments on note payable	(18)	(18)
Payments to parent	(441)	(45)
Cash used in financing activities	(459)	(63)
Increase (decrease) in cash and cash equivalents	12,454	289
Cash and cash equivalents, beginning of period	12,586	11,995
Cash and cash equivalents, end of period	25,040	12,284
Reportable Entities [Member] \| Non-Guarantor Subsidiaries [Member]
Condensed Cash Flow Statements, Captions [Line Items]
Cash provided by operating activities	(1,132)	(1,812)
Cash flows from investing activities
Capital expenditures	(122)	(17)
Cash used in investing activities	(122)	(17)
Cash flows from financing activities
Effect of foreign exchange rate on cash	(196)	(41)
Increase (decrease) in cash and cash equivalents	(1,450)	(1,870)
Cash and cash equivalents, beginning of period	5,231	4,674
Cash and cash equivalents, end of period	3,781	2,804
Eliminations [Member]
Cash flows from investing activities
Payments from subsidiary	(441)	(45)
Cash used in investing activities	(441)	(45)
Cash flows from financing activities
Payments to parent	441	45
Cash used in financing activities	$ 441	$ 45

Condensed Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Current assets
Cash and cash equivalents	$ 28,821	$ 17,817
Accounts receivable, net of allowance of $471 and $585	38,401us-gaap_AccountsReceivableNetCurrent	41,540us-gaap_AccountsReceivableNetCurrent
Inventory	16,153us-gaap_InventoryNet	15,582us-gaap_InventoryNet
Income tax receivable	157us-gaap_IncomeTaxesReceivable	247us-gaap_IncomeTaxesReceivable
Deferred tax assets	255us-gaap_DeferredTaxAssetsNetCurrent	256us-gaap_DeferredTaxAssetsNetCurrent
Other current assets	4,795us-gaap_OtherAssetsCurrent	3,739us-gaap_OtherAssetsCurrent
Total current assets	88,582us-gaap_AssetsCurrent	79,181us-gaap_AssetsCurrent
Property, plant and equipment, net	92,102us-gaap_PropertyPlantAndEquipmentNet	96,014us-gaap_PropertyPlantAndEquipmentNet
Capitalized software development costs, net	2,268us-gaap_CapitalizedComputerSoftwareNet	2,421us-gaap_CapitalizedComputerSoftwareNet
Intangibles, net	25,582us-gaap_FiniteLivedIntangibleAssetsNet	27,191us-gaap_FiniteLivedIntangibleAssetsNet
Goodwill	15,714us-gaap_Goodwill	15,714us-gaap_Goodwill
Deferred financing costs	6,668	7,349
Deferred tax assets	334	328
Other long-term assets	17,486us-gaap_OtherAssetsNoncurrent	19,318us-gaap_OtherAssetsNoncurrent
Total assets	248,736us-gaap_Assets	247,516us-gaap_Assets
Current liabilities
Line of credit	8,000us-gaap_LinesOfCreditCurrent	8,000us-gaap_LinesOfCreditCurrent
Accounts payable	13,053us-gaap_AccountsPayableCurrent	15,665us-gaap_AccountsPayableCurrent
Accrued expenses and other liabilities	29,876	24,579
Deferred tax liability	148	152
Deferred revenue	129us-gaap_DeferredRevenueCurrent	132us-gaap_DeferredRevenueCurrent
Total current liabilities	51,206us-gaap_LiabilitiesCurrent	48,528us-gaap_LiabilitiesCurrent
Asset retirement obligation	7,373	7,435
Long-term debt, net	399,348us-gaap_LongTermDebtNoncurrent	399,280us-gaap_LongTermDebtNoncurrent
Deferred tax liability	246	247
Other long-term liabilities	31,106us-gaap_OtherLiabilitiesNoncurrent	32,995us-gaap_OtherLiabilitiesNoncurrent
Total liabilities	489,279us-gaap_Liabilities	488,485us-gaap_Liabilities
Commitments and contingencies (See Note 13)
Stockholder's deficit
Common stock ($0.001 par value, 10,000 shares authorized; 1 share issued and outstanding)	0us-gaap_CommonStockValue	0us-gaap_CommonStockValue
Due from parent	(3,916)ck0001500157_AmountsDueFromAffiliates	(3,766)ck0001500157_AmountsDueFromAffiliates
Additional paid-in capital	4,211	3,934
Accumulated deficit	(238,850)	(239,507)
Accumulated other comprehensive loss	(1,988)	(1,630)
Total stockholder's deficit	(240,543)us-gaap_StockholdersEquity	(240,969)us-gaap_StockholdersEquity
Total liabilities and stockholder's deficit	$ 248,736	$ 247,516